Skip to content
Home
About Us
Board Members
Our Markets
Mission & Guiding Principles
Services
Medical Affairs
Marketing & Sales
Market Access
Pharmacovigilance/QA Support
Regulatory Affairs
Logistics and Tendering
Independent Compliance
Partners
News/Updates
WODA
Home
About Us
Board Members
Our Markets
Mission & Guiding Principles
Services
Medical Affairs
Marketing & Sales
Market Access
Pharmacovigilance/QA Support
Regulatory Affairs
Logistics and Tendering
Independent Compliance
Partners
News/Updates
WODA
Contact Us
News & Updates
World Orphan Drug Alliance – Vector as founding Member
May 12, 2022
Read More »
EVERSANA™ and Vector Pharma FZCO Announce Strategic Partners
April 28, 2022
Read More »
Maria Teresa Rico Perez as Independent Compliance Lead
November 30, 2021
Read More »
Page
1
Page
2
Page
3
Biospace News Feed
Mineralys’ Hypertension Drug Drops Blood Pressure in Phase II/III, Setting Up Market Clash
Novo Dips After CagriSema’s Latest Lower-Than-Expected Weight Loss Readout
BMS’ Sotyktu Notches Phase III Win in Psoriatic Arthritis
J&J’s Oral IL-23R Blocker Sets New Standard in Plaque Psoriasis, Beating BMS’ Sotyktu
Amgen’s Rocatinlimab Picks Up Steam With Late-Stage Atopic Dermatitis Win
Employers’ Markets Don’t Last, Companies Should Focus on Purpose-Driven Culture
FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
Novavax Applies Lessons Learned From Turbulent COVID-19 Experience
GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates
FDA Action Alert: GSK, Alnylam, Sanofi and More
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency
Atea Pharmaceuticals Cuts 25% of Workforce
Novo’s Studies of GLP-1s for Addiction Limited to Ongoing Phase II
AstraZeneca Builds Stomach Cancer Case for Imfinzi With Strong Phase III Data
Biospace News Feed